Posts by Christopher J. Hartnick, MD, MS
Changing Lives With a Device for the Tongue
A new study from Mass Eye and Ear has proven the safety and efficacy of using hypoglossal nerve stimulation to treat obstructive sleep apnea in children with Down syndrome—and has uncovered exciting new clues on the treatment's impact on neurocognition.
Artificial Intelligence Improves Diagnosis of Pediatric Middle Ear Effusion
Matthew G. Crowson, MD, MPA, MASc, Michael S. Cohen, MD, Christopher J. Hartnick, MD, and colleagues trained a neural network to diagnose pediatric middle ear effusion using a novel approach: the training set of images were tympanic membrane photos taken during myringotomy. When applied to a test set, the algorithm's diagnostic accuracy was 84%.
With more than 15 years of experience in pediatric otolaryngology, Dr. Christopher Hartnick serves as the Director of the Pediatric Otolaryngology Division and the Director of the Pediatric Airway, Voice, and Swallowing Center at Massachusetts Eye and Ear.
Dr. Hartnick has been an invited speaker at regional, national, and international meetings and has published more than 150 peer-reviewed papers in the field. He serves as the Physician Director on the Mass Eye and Ear Board of Directors and is the Vice Chair of Clinical Trials and Outcomes for the Department of Otolaryngology. He is an editor for ENT Journal, a reviewer for Journal of Voice, and an ad-hoc reviewer for several other publications.
Fellowship-trained and board-certified in otolaryngology, Dr. Hartnick’s clinical interests include pediatric airway and pediatric voice. His primary research interests include the development of maturation of the pediatric vocal fold, pediatric voice disturbances, and pediatric outcomes studies.
He is also the Benjamin Harry Peikin Chair in Otolaryngology–Head and Neck Surgery.